SCHEMBL6803202

SCHEMBL6803202

CNC(=O)C(Cc1ccc([N+](=O)[O-])cc1)NC(=O)CCc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.55
KMT2A Q03164 1/20 0.55
MMP1 P03956 5/20 0.53
FCER2 P06734 2/20 0.53
ALDH1A1 P00352 1/20 0.53
LMNA P02545 1/20 0.53
MMP3 P08254 3/20 0.52
HDAC8 Q9BY41 2/20 0.51
CTSL P07711 2/20 0.50
NPC1 O15118 1/20 0.50
TP53 P04637 1/20 0.50
RAB9A P51151 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
PTPN1 P18031 1/20 0.49
HDAC3 O15379 1/20 0.49
HDAC4 P56524 1/20 0.49
HDAC1 Q13547 1/20 0.49
HDAC7 Q8WUI4 1/20 0.49
HDAC2 Q92769 1/20 0.49
HDAC10 Q969S8 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6803737 1.00 MEN1 (0.55) MEN1KMT2AMMP1FCER2ALDH1A1
SCHEMBL6803191 1.00 MEN1 (0.55) MEN1KMT2AMMP1FCER2ALDH1A1
SCHEMBL4457674 0.91 MMP1 (0.52) MEN1KMT2AMMP1FCER2LMNA
SCHEMBL6828040 0.88 MEN1 (0.70) MEN1KMT2AMMP1FCER2ALDH1A1
SCHEMBL6828028 0.88 MEN1 (0.70) MEN1KMT2AMMP1FCER2ALDH1A1
SCHEMBL6911348 0.83 L3MBTL1 (0.45) MEN1KMT2AMMP1FCER2ALDH1A1
SCHEMBL6911343 0.83 L3MBTL1 (0.45) MEN1KMT2AMMP1FCER2ALDH1A1
SCHEMBL6807421 0.82 NPC1 (0.62) MEN1KMT2AMMP1FCER2ALDH1A1
SCHEMBL6807425 0.82 NPC1 (0.62) MEN1KMT2AMMP1FCER2ALDH1A1
SCHEMBL6807041 0.82 ANPEP (0.60) MEN1KMT2AMMP1FCER2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004074238-A1 PHENETHYLAMINO SULFAMIC ACIDS THE PROCTER & GAMBLE COMPANY (US) 2004-09-02 WO disclosed
US-20040167183-A1 Phenethylamino sulfamic acids THE PROCTER & GAMBLE COMPANY 2004-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040167183-A1 Phenethylamino sulfamic acids PTPRM, PTPRS, PTPRE MEN1 4379/4885KMT2A 2262/4885MMP1 857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.